Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 166.50
+2.50 (1.52%)
At close: Dec 12, 2025
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 258.22 billion as of December 12, 2025. Its market cap has increased by 218.13% in one year.
Market Cap
258.22B
Enterprise Value
251.71B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
166.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 258.22B, an increase of 3,144.68%. That is a compound annual growth rate of 223.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 257.45B | 172.82% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 189.36B |
| Heron Neutron Medical | 92.80B |
| Lotus Pharmaceutical | 76.66B |
| Bora Pharmaceuticals Co., LTD. | 63.95B |
| Lin BioScience | 35.24B |
| Lumosa Therapeutics | 32.68B |
| Oneness Biotech | 29.09B |
| Center Laboratories | 27.81B |